These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9932643)

  • 1. Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T).
    Tsukagoshi H; Nagashima M; Horie T; Oyama T; Yoshii A; Sato T; Iizuka K; Dobashi K; Mori M
    Intern Med; 1998 Dec; 37(12):1064-7. PubMed ID: 9932643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness.
    Horiguchi T; Tachikawa S; Handa M; Hanazono K; Kondo R; Ishibashi A; Banno K
    J Asthma; 2001 Jun; 38(4):331-6. PubMed ID: 11456386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
    Zhao GD; Yokoyama A; Kohno N; Sakai K; Hamada H; Hiwada K
    Int Arch Allergy Immunol; 2000 Feb; 121(2):116-22. PubMed ID: 10705221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kimura's disease treated with suplatast tosilate and loratadine.
    Ueda T; Arai S; Amoh Y; Katsuoka K
    Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
    Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
    J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
    Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
    Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response.
    Yanagihara Y; Kiniwa M; Ikizawa K; Shida T; Matsuura N; Koda A
    Jpn J Pharmacol; 1993 Jan; 61(1):31-9. PubMed ID: 8382323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines.
    Oda N; Minoguchi K; Yokoe T; Hashimoto T; Wada K; Miyamoto M; Tanaka A; Kohno Y; Adachi M
    Life Sci; 1999; 65(8):763-70. PubMed ID: 10466742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
    Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
    Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
    Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
    Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug.
    Suwaki T; Agrawal DK; Townley RG
    Int Immunopharmacol; 2001 Nov; 1(12):2163-71. PubMed ID: 11710545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
    Yamasawa H; Oshikawa K; Sugiyama Y
    Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
    Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
    J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
    Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
    Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of chronic eosinophilic pneumonia with suplatast tosilate].
    Kusumoto H; Mizuno K; Yonemaru M; Nakano M; Ichinose Y; Toyama K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):550-4. PubMed ID: 9234634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
    Kirimoto T; Nakano K; Irimura K; Hayashi Y; Matsuura N; Kiniwa M; Oka T; Yoshimura N
    BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
    Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
    J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.